Pharmaceutical composition used for treating leukemia

Abstract

The invention relates to a pharmaceutical composition used for treating leukemia. The pharmaceutical composition is prepared by taking morin, podophyllotoxin, rhodioloside, and sarmentosin as drug substances via mixing. Different dosage forms can be obtained via conventional pharmaceutical technology. The pharmaceutical composition is capable of improving activity of NCK, IL-2, IL-6, and IFN-gamma, and possesses high application value in treatment of leukemia.

Description

technical field [0001] The invention belongs to the field of medicine and relates to a pharmaceutical composition for treating leukemia. Background technique [0002] Leukemia is a malignant tumor of the hematopoietic system, characterized by the progressive and uncontrolled abnormal proliferation of white blood cells and their immature cells, as well as immature red blood cells or megakaryocytes (ie, leukemia cells) in the bone marrow or other hematopoietic tissues, infiltrating the whole body Various tissues and organs, and enter the peripheral blood. According to the degree of leukemia cell maturity and the natural process of leukemia, leukemia can be divided into two categories: acute leukemia and chronic leukemia. Acute leukemia has a sudden onset, and symptoms such as anemia, hemorrhage, secondary infection, and fever are caused by the reduction of normal red blood cells. In addition, due to the extensive infiltration of leukemia cells in various tissues and organs, ...

AI Technical Summary

Problems solved by technology

However, due to many unresolved problems such as the side effects of chemotherapy drugs and the difficulty of bone marrow source, people are always looking for new treatment strategies